Nanopore Sequencing Patent Landscape Report and Forecast 2024-2032

The nanopore sequencing market was valued at USD 271.64 million in 2023. It is expected to grow at a CAGR of 11.2% during the forecast period of 2024-2032 and attain a market value of USD 706.21 million in 2032. The growth is driven by a surge in patent applications, spurred by cutting-edge advancements in nanopore sequencing and genomic research.

Patent Landscape Report Coverage

The global nanopore sequencing patent landscape report delves into the dynamic field of nanopore sequencing. It highlights critical advancements in novel materials, portable devices, and real-time data algorithms. The report showcases patent trends across product types, applications, and end users, emphasizing innovations in DNA/RNA sequencing technologies. Key players like Oxford Nanopore Technologies and Cyclomics BV are detailed. Regional insights spotlight the US, Europe, and Asia, highlighting their unique strengths and roles in shaping nanopore sequencing's future.

Global Nanopore Sequencing Patent Outlook

• Advancements in genomics and molecular biology drive the nanopore sequencing patent landscape. Key patents focus on novel materials like graphene and synthetic polymers, improving accuracy, speed, and performance. Portable devices and real-time data analysis algorithms are also key. These advancements are fueling growth in clinical diagnostics and other fields.
• Leading biotech companies and research institutions like Oxford Nanopore Technologies, Cyclomics BV, and Grandomics Biosciences Co., Ltd. are dominating the nanopore sequencing patent landscape with innovative methodologies, device designs, and data processing techniques. Their contributions are shaping the evolution and widespread adoption of nanopore sequencing technologies.
• The worldwide nanopore sequencing patent landscape shows strong regional participation, with the United States leading with over 900 patents due to research funding and supportive regulations. Europe has around 700 patents thanks to biotech investments and strong collaborations, notably in the UK and Germany. Asia, particularly China and Japan, holds about 500 patents, showing progress and government backing in biotechnology. The varied strengths of these regions are vital for the future of nanopore sequencing technologies.

Nanopore Sequencing Introduction

Nanopore sequencing is a cutting-edge technology that enables the real-time analysis of DNA and RNA molecules. This method uses nanopores tiny holes through which individual nucleic acid strands are passed allowing the sequencing of long fragments of DNA or RNA with high accuracy and speed. Unlike traditional sequencing techniques, nanopore sequencing does not require amplification, reducing time and potential errors. Its portability and scalability make it ideal for a wide range of applications, from clinical diagnostics to environmental monitoring. As technology advances, nanopore sequencing continues to revolutionise genomics, offering unprecedented insights into genetic information and complex biological systems.

• Patents on novel nanopore materials, such as graphene and synthetic polymers, are expanding the patent landscape. These innovations enhance sequencing accuracy, speed, and performance while broadening application scopes. This surge in patent activity drives significant advancements in nanopore sequencing technologies, fostering further research and development in the field.
• Patents focused on portable nanopore sequencing devices are expanding the patent landscape. These patents cover compact, user-friendly designs that facilitate real-time DNA/RNA analysis in diverse settings, from clinical diagnostics to field research. This innovation drives significant advancements in accessibility and practical applications of nanopore sequencing technologies.
• Patents on real-time data analysis algorithms for nanopore sequencing are expanding the patent landscape. These innovations enhance sequencing accuracy and efficiency by processing data instantaneously, providing immediate insights and applications. This advancement significantly boosts the utility and appeal of nanopore technology, driving further development and adoption.

These drivers create a dynamic, rapidly evolving nanopore sequencing patent landscape, fostering innovation and wider use.

Global Nanopore Sequencing Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation:

Analysis by Product

• Instruments
• Consumables

The patent segments in the nanopore sequencing industry by product, specifically instruments and consumables, demonstrate notable advancements. Instruments dominate the patent landscape with over 600 patents historically filed and 250 currently in process. These patents drive innovation in sequencing technology, enhancing accuracy and efficiency. Such advancements are poised to drive future growth, cementing their role in advancing genomic research and diagnostics, and broadening the applicability of nanopore sequencing technologies, thus propelling the field forward in the forecast period.

Analysis by Application

• DNA Sequencing
• RNA Sequencing

The patent segments in the nanopore sequencing industry by application, specifically DNA sequencing and RNA sequencing, demonstrate notable advancements. DNA Sequencing dominates the patent landscape with over 700 patents historically filed and 300 currently in process. These patents drive innovation in sequencing methodologies, enhancing accuracy and speed. Such advancements are poised to drive future growth, cementing their role in advancing genomic research and diagnostics, and broadening the applicability of nanopore sequencing technologies, thus propelling the field forward in the forecast period.

Analysis by End User

• Hospitals
• Academic and Research Institute
• Others

The patent segments in the global nanopore sequencing industry by end user, specifically hospitals, academic and research institutes, and others, demonstrate notable advancements. Academic and Research Institutes dominate the patent landscape with over 800 patents historically filed and 350 currently in process. These patents drive innovation in sequencing technologies and applications, enhancing research capabilities and precision diagnostics. Such advancements are poised to drive future growth, cementing their role in advancing genomic studies and personalized medicine, thus broadening the applicability of nanopore sequencing and propelling the field forward in the forecast period.

Nanopore Sequencing Patent Jurisdiction Analysis

The global landscape for nanopore sequencing patents is rapidly evolving, with significant activity across key regions including the United States, Europe, and Asia. Each jurisdiction shows unique trends in patent filings and company involvement, reflecting regional interests and advancements in this innovative field.

• The United States leads the nanopore sequencing patent landscape with over 900 patents. This is driven by robust research funding from government and private sectors and a supportive regulatory environment. Major biotech firms and advanced research institutions significantly contribute to patent filings, maintaining the US at the forefront of developing and commercialising cutting-edge nanopore sequencing technologies.
• Europe follows with around 700 patents, benefiting from substantial biotech investments and strong collaborative networks, particularly in the UK and Germany. European research institutions and companies are known for innovative sequencing technologies. The European Union’s supportive policies and funding programs bolster patent activity, advancing nanopore sequencing in personalized medicine and diagnostics.
• Asia, especially China and Japan, holds approximately 500 patents. This reflects rapid advancements and substantial government support in biotechnology. China’s aggressive biotech research funding and Japan’s focus on precision medicine contribute to the growing patent landscape, highlighting the region’s expanding influence in the global nanopore sequencing industry.

Patent Profile of Key Companies

The patent landscape for nanopore sequencing is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities.

Oxford Nanopore Technologies

Oxford Nanopore Technologies is a leader in the nanopore sequencing patent landscape, with numerous patents covering innovations in portable and scalable sequencing devices. Their continuous advancements in real-time data analysis and long-read sequencing significantly enhance nanopore technology's accuracy and application scope.

Cyclomics BV

Cyclomics BV focuses on developing nanopore sequencing technologies for cancer diagnostics. Their patents primarily cover methods for detecting circulating tumor DNA, leveraging nanopore sequencing's high sensitivity and precision. Cyclomics BV’s innovations are pivotal in advancing non-invasive cancer detection and monitoring.

Grandomics Biosciences Co., Ltd

Grandomics Biosciences Co., Ltd holds several patents in nanopore sequencing, emphasising ultra-long read sequencing capabilities. Their patented technologies enhance genomic research, enabling comprehensive analysis of complex genomes. Grandomics’ contributions are vital for expanding the applications of nanopore sequencing in genomics and personalized medicine.

Other key players in the industry include Electronic Biosciences LLC. and INanoBio Inc.

Key Questions Answered in the Global Nanopore Sequencing Patent Landscape Report

• What are the current industry size and projected growth of the nanopore sequencing industry from 2024 to 2032?
• How do patent applications in nanopore sequencing correlate with technological advancements in genomics and molecular biology?
• What are the critical advancements in nanopore sequencing technologies, specifically in novel materials, portable devices, and real-time data algorithms?
• How do patents in DNA sequencing and RNA sequencing applications drive the landscape forward?
• What roles do different end users, including hospitals and academic research institutes, play in the nanopore sequencing patent landscape?
• What are the implications of patent filings in nanopore sequencing?
• What are the challenges and opportunities in the nanopore sequencing patent landscape?
• What are the regulatory and legal considerations associated with nanopore sequencing patents?
• What technological innovations have recently emerged in nanopore sequencing?
• How do specific patents on novel nanopore materials, portable devices, and real-time data analysis algorithms contribute to advancements in the field?
• What are the competitive dynamics and emerging opportunities in the nanopore sequencing patent landscape?
• How can stakeholders leverage information from the nanopore sequencing patent landscape for strategic decision-making and innovation?

Reasons to Purchase this Report

This report offers a comprehensive analysis of the global nanopore sequencing patent landscape, highlighting market size, growth trends, and key technological advancements. It provides detailed insights into patent segmentation by product type, application, end user, and jurisdiction, revealing significant areas of innovation and activity. By examining the strategies and patent portfolios of leading companies, the report provides a clear understanding of competitive dynamics and emerging opportunities. Stakeholders gain valuable information on patent trends, technological developments, and potential investment areas, aiding strategic decision-making and fostering innovation in nanopore sequencing technologies.


This product will be delivered within 5-7 business days.